Print

TheragenicsĀ® Reports Revenue and Earnings for Third Quarter 2012  
11/8/2012 11:01:17 AM

BUFORD, Ga.--(BUSINESS WIRE)--Theragenics CorporationĀ® (NYSE: TGX), a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the third quarter ended September 30, 2012.
//-->